Ram Garg, MD
Neurology · Taylor, MINPI 1164402442
Payments from drug & device makers
Across 1,562 payments — averaging $71.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$38K
- Eisai Inc.$25K
- Sanofi$12K
- SK Life Science, Inc.$9K
- Teva Pharmaceuticals USA, Inc.$7K
- Biogen$3K
- plus $17K from 47 others
What the payments were for
- Consulting fees$11,53510%
- Speaking & faculty fees$69,72763%
- Travel & lodging$5,1745%
- Food & beverage$24,31622%
- Education$1590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$110,911 in reported general payments places this provider in the 85th percentile of 652 neurology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 37 | $328,963 |
| BetaseronInterferon Beta-1b | 28 | $257,736 |
| TysabriNatalizumab | 30 | $247,807 |
| Kesimpta PenOfatumumab | 25 | $243,893 |
| BriviactBrivaracetam | 124 | $191,713 |
| EpidiolexCannabidiol (Cbd) | 27 | $174,254 |
| FingolimodFingolimod Hcl | 19 | $122,147 |
| AptiomEslicarbazepine Acetate | 62 | $120,393 |
| Avonex (4 Pack)Interferon Beta-1a | 12 | $101,674 |
| VumerityDiroximel Fumarate | 11 | $93,067 |
| FycompaPerampanel | 69 | $81,151 |
| RexultiBrexpiprazole | 42 | $60,241 |
| ValtocoDiazepam | 44 | $57,341 |
| EliquisApixaban | 40 | $31,393 |
| NayzilamMidazolam | 27 | $29,207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BiogenTysabri, Avonex (4 Pack), Vumerity | $2,579 | $442,54853 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $6,890 | $328,96337 claims |
| UCB, Inc.Briviact, Nayzilam, Vimpat, Neupro | $2,116 | $253,551181 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $464 | $120,39362 claims |
| Eisai Inc.Fycompa | $25,157 | $81,15169 claims |
| AbbVieVraylar, Ubrelvy, Qulipta, Linzess | $38,062 | $71,95869 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $52 | $60,24142 claims |
| Neurelis, Inc.Valtoco | $484 | $57,34144 claims |
| PfizerEliquis, Nurtec Odt | $236 | $52,90153 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $442 | $21,08045 claims |
| SK Life Science, Inc.Xcopri | $9,161 | $18,36814 claims |
| Neurocrine Biosciences, Inc.Ongentys | $956 | $13,08219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 652 neurology providers in Michigan.
Other neurology in Taylor
- Aaron EllenbogenFarmington Hills$14.5M
- Martin BelkinFarmington Hills$5.8M
- Evanthia BernitsasDetroit$4.8M
- Yang Mao DraayerFarmington Hills$4.2M
- Mirela CerghetDetroit$3.8M
- Peter le WittWest Bloomfield$3.2M
- Judith HeidebrinkAnn Arbor$2.2M
- Denise LeungAnn Arbor$2M
- Rany AburashedOwosso$1.9M
- Jeanie CoteOwosso$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.